Enzon Pharmaceuticals Inc

-0.98% -1 pts during the current or most recent trading day
Spread Bet: DFB Ways to deal
Delayed Prices
or Sign up to see live prices
Sell 100.0
Buy 100.0
Product details
or create an account to see actual figures the moment they’re released
  • Day
  • Week
  • Month
Today
or create an account to see actual figures the moment they’re released
  • Day
  • Week
  • Month
 
Copyright 2014 Thomson Reuters Ltd.  Click for restrictions
Open High Low Change % Change
102 109 98 -1 -0.98

BRIEF: For the six months ended 30 June 2014, Enzon Pharmaceuticals Inc revenues decreased 8% to $16.7M. Net income increased from $7.1M to $15.4M. Revenues reflect Royalties decrease of 5% to $16.7M, Miscellaneous income decrease of 90% to $62K. Net income reflects General and administrative decrease of 75% to $1.3M (expense), Restructuring charges decrease from $3M (expense) to $0K, Interest expense decrease from $2.1M (expense) to $0K.

2014-09-03T17:49:52+00:00

Net Income

Income Statement

Total Equity

Balance Sheet

Cash from Operating Activities

Cash Flow

Our shares technology

Start trading with IG

* Open a stockbroking account and place your first trade before 31 December 2014 and get commission-free trades on all stocks for one calendar month from the date of your first trade. Does not apply to trades placed over the phone. If your free month expires before 31 December 2014, we'll give you a reduced rate of £6 per trade on UK stocks until the end of the year. Our normal stockbroking charges and fees will apply once the offer period is complete. See full terms and conditions.

Trade shares with IG

Enjoy commission-free* stockbroking  
online for one month

Learn more

  • 100% of IG client accounts with open positions in this market expect the price to rise
  • 0% of IG client accounts with open positions in this market expect the price to fall
  • < 10 IG client accounts have open positions in this market
  1. Last hour
    No trades
  2. Today
    No trades
  3. This week
    No trades
  4. This month
    50%

Related

  • Global
  • United States
Market cap
Biota Pharmaceuticals Inc USD 86.00M
Cardiome Pharma Corp USD 139.82M
Dendreon Corp USD 166.73M
Amarin Corp PLC - ADR USD 182.84M
Pain Therapeutics Inc USD 188.06M
SurModics Inc USD 281.32M
Exelixis Inc USD 319.98M

Events

  • Past
  • Future
  • AUG
    08
    Q2 2014 ENZON PHARMACEUTICALS INC Earnings Release
    2 months ago